Low Preoperative Hemoglobin Predicts Worse Survival in Resectable NSCLC

Summary: Doctors looked at patients with lung cancer who received chemotherapy and immunotherapy before having surgery to remove their tumors. They found something very important: a patient's blood health right before surgery matters a lot.

During treatment, the patients' hemoglobin (the part of red blood cells that carries oxygen) often dropped. The study showed that patients whose hemoglobin fell below 10 g/dL right before their operation had a much lower chance of survival compared to those with higher levels.

This means doctors need to pay close attention to red blood cell levels and might need to find ways to boost a patient's blood health before sending them into lung surgery.

For more details, see Pulmonology Advisor at pulmonologyadvisor.com/news/low-preoperative-hemoglobin-predicts-worse-survival-in-resectable-nsclc/ (opens in new tab)